Should the HHS Secretary be able to fire and replace the members of the U.S. Preventive Services Task Force?
Why it's live: Secretary Kennedy cancelled the USPSTF's
July meeting and — after removing chair John Wong and vice-chair Esa Davis — signaled he intends
to replace all 16 members. The panel hasn't formally met in roughly a year, and last June's Supreme
Court Kennedy v. Braidwood ruling handed the Secretary supervisory authority over it, so the
fight is now about whether he should use it this way.
The case for
An unelected volunteer panel whose "A" and "B" ratings automatically trigger
mandatory, no-cost insurance coverage is wielding what amounts to legislative power — and power
like that, the argument goes, should answer to an accountable, Senate-confirmed official rather
than to itself. That's the reasoning the Court blessed in Braidwood. Kennedy's
termination letters framed the removals as housekeeping to "preserve the validity of future task
force actions," and note members are free to reapply. Supporters insist oversight isn't the same
thing as politicization.
AJMC
The case against
The USPSTF's whole value is its insulation from politics: its recommendations set screening for
cancer, diabetes and heart disease, and clinicians trust them because they follow a transparent,
evidence-only process. The AMA (president Bobby Mukkamala) and AAFP,
joined by Senators Angus King and Kirsten Gillibrand, warn that reconstituting the panel wholesale
risks the same erosion of trust that followed the ACIP vaccine-panel overhaul — and could put
guaranteed preventive-care coverage in jeopardy. Founding chair Robert Lawrence and adviser Steven
Woolf made the same case in an Annals op-ed.
AMA ·
Senate letter
Where it might land: whoever Kennedy names could reset years of
screening recommendations — and those flow straight into what your patients get covered. Worth watching
the appointment list.